SavedAdd your journal

Journals / Eskişehir Teknik Üniversitesi Bilim ve Teknoloji Dergisi - C Yaşam Bilimleri Ve Biyoteknoloji / 2011 / Cilt: 1 - Sayı: 2

SYNTHESIS OF SOME N-(BENZOTHIAZOL-2-YL)-2-(4H-[1,2,4]TRIAZOL -3- YLSULFANYL)ACETAMIDES AND THEIR ANTIMICROBIAL ACTIVITY

BAZI N-(BENZOTİYAZOL-2-İL)-2-(4H-[1,2,4]TRİAZOL-3- İLSÜLFANİL)ASETAMİDLERİN SENTEZİ VE BUNLARIN ANTİMİKROBİYAL AKTİVİTELERİ

Ahmet ÖZDEMİR
Zafer KAPLANCIKLI
Gülhan TURAN-ZITOUNI
Mehlika ALTINTOP
Fatih DEMİRCİ
Pages
145–151
Publication Date
2011-07-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results showed that all of the tested compounds were inactive against the test organism.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study is to synthesize novel benzothiazolyl-amide derivatives and investigate their antimicrobial activities.
📊
Key Findings & Data:N-(Benzothiazol-2-yl)-2-(4H-[1,2,4]triazol-3-ylsulfanyl) acetamide derivatives were prepared by the reaction of N-(benzothiazol-2-yl)-2-chloroacetamides with appropriate 4H-[1,2,4]triazol-2-thione.
💡
Conclusion & Impact:The results showed that all of the tested compounds were inactive against the test organism.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Benzotiyazol · Triazol · Antimikrobiyal aktivite

Abstract

The aim of this study is to synthesize novel benzothiazolyl-amide derivatives and investigate their antimicrobial activities. N-(Benzothiazol-2-yl)-2-(4H-[1,2,4]triazol-3-ylsulfanyl) acetamide derivatives were prepared by the reaction of N-(benzothiazol-2-yl)-2-chloroacetamides with appropriate 4H-[1,2,4]triazol-2-thione. The chemical structures of the compounds were elucidated by elemental analyses, IR, 1H-NMR, 13C-NMR and FAB+-MS spectral data. Their antimicrobial activities against Escherichia coli (NRRL B-3008), Staphylococcus aureus (ATCC 6538), Pseudomonas aeruginosa (ATCC 27853), Proteus vulgaris (NRRL B-123), Salmonella typhimurium (ATCC 13311), Methicillin-resistant Staphylococcus aureus (MRSA) (clinic isolate), Candida albicans (NRRL Y-12983) and Candida parapsilosis (NRRL Y-12696) were investigated. The results showed that all of the tested compounds were inactive against the test organism.

Özet

Bu çalışmanın amacı, yeni benzotiyazolil-amid türevlerini sentezlemek ve bunların antimikrobiyal aktivitelerini araştırmaktır. N-(benzotiyazol-2-il)-2-kloroasetamidler ile uygun 4H-[1,2,4]triazol-2tiyonların reaksiyona sokulmasıyla N-(Benzotiyazol-2-il)-2-(4H-[1,2,4]triazol-3-ilsülfanil) asetamid türevleri hazırlanmıştır. Sentezlenen bileşiklerin kimyasal yapıları elemental analiz, IR, 1H-NMR, 13CNMR ve FAB+-MS spektral verileri ile aydınlatılmıştır. Bunların antimikrobiyal aktiviteleri Escherichia coli (NRRL B-3008), Staphylococcus aureus (ATCC 6538), Pseudomonas aeruginosa (ATCC 27853), Proteus vulgaris (NRRL B-123), Salmonella typhimurium (ATCC 13311), Methicillin-resistant Staphylococcus aureus (MRSA) (clinic isolate), Candida albicans (NRRL Y-12983) ve Candida parapsilosis’e (NRRL Y-12696) karşı araştırılmıştır. Sonuçlar test edilen tüm bileşiklerin, test organizmalarına karşı inaktif olduğunu gösterdi

🔖

Cite This Article

ÖZDEMİR, A., KAPLANCIKLI, Z., TURAN-ZITOUNI, G., ALTINTOP, M., DEMİRCİ, F. (2011). SYNTHESIS OF SOME N-(BENZOTHIAZOL-2-YL)-2-(4H-[1,2,4]TRIAZOL -3- YLSULFANYL)ACETAMIDES AND THEIR ANTIMICROBIAL ACTIVITY. Eskişehir Teknik Üniversitesi Bilim ve Teknoloji Dergisi - C Yaşam Bilimleri Ve Biyoteknoloji, Cilt: 1 - Sayı: 2, 145–151. https://ajindex.com/articles/755421

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Ali, A., Taylor, G.E. and Graham, D.W. (2001). PCT Int. Appl. WO 2001028561. Bayrak, H., Demirbas, A., Demirbas, N. and Karaoglu, S.A. (2009). Synthesis of some new 1,2,4-triazoles starting from isonicotinic acid hydrazide and evaluation of their antimicrobial activities. Eur. J. Med. Chem. 44, 4362-4366.
  2. Bhargava, P.N. and Ram, P. (1965). Synthesis of local anesthetics. Bull. Chem. Soc. Japan 38, 339-341.
  3. Black, C., Deschenes, D., Gagnon, M., Lachance, N., Leblanc, Y., Leger, S., Li, C.S. and Oballa, R.M. (2006). PCT Int. Appl. WO 2006122200 A1 20061116. Blackman, A.J. and Polya, J.B. (1970). Triazoles. Part XI. Synthesis of 1,2,4-Triazole-3-sulphonic Acids by Oxidation of 1,2,4-Triazoline-3-thiones. J. Chem. Soc. (C) 2403-2409.
  4. Bose, D.S. and Idrees, M. (2010). Intramolecular Cascade C-S Bond Formation: Regioselective Synthesis of Substituted Benzothiazoles, Synthesis 12, 1983-1988.
  5. Koneman, E.W., Allen, S.D. and Winn, W.C. (1997). Colour Atlas and Textbook of Diagnostic Microbiology. Lippincott Raven Publishers,
  6. Philadelphia, USA, pp. 86-856.
  7. Henriksen, G., Hauser, A.I., Westwell, A.D., Yousefi, B.H., Schwaiger, M., Drzezga, A. and Wester, H.J. (2007). Metabolically stabilized benzothiazoles for imaging of amyloid plaques. J. Med. Chem. 50, 10871089. Hutchinson, I., Chua, M.S., Browne, H.L., Trapani, V., Bradshaw, T.D., Westwell, A.D. and Stewens, M.F.G. (2001). Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4aminophenyl)benzothiazoles. J. Med. Chem. 44, 1446-1455.
  8. NCCLS (2002). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard-Second Edition, NCCLS document M27-A2, ISBN 1-56238-469-4.
  9. Palmer, P.J., Trigg, R.B. and Warrington, J.V. (1971). Benzothiazolines as antituberculous agents. J. Med. Chem. 14, 248-251.
  10. Saadeh, H.A., Mosleh, I.M., Al-Bakri, A.G. and Mubarak, M.S. (2010). Synthesis and antimicrobial activity of new 1,2,4-triazole-3-thiol metronidazole derivatives. Monatsh. Chem. 141, 471-478.
  11. Shaker, R.M. (2006). The chemistry of mercapto-and thione- substituted 1,2,4-triazoles and their utility in heterocyclic synthesis. Arkivoc ix, 59-112.
  12. Swamy, S.N., Basappa Priya, B.S., Prabhuswamy, B., Doreswamy, B.H., Prasad, J.S. and Rangappa, K.S. (2006). Synthesis of pharmaceutically important condensed heterocyclic 4,6-disubstituted-1,2,4-triazolo-1,3,4-thiadiazole derivatives as antimicrobials. Eur. J. Med. Chem. 41, 531-538.